• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incomplete stent apposition after coronary stent implantation: myth or reality?

作者信息

Rathore Sudhir, Terashima Mitsuyasu, Habara M, Kinoshita Yoshihisa, Nasu Kenya, Katoh Osamu, Suzuki Takahiko

机构信息

Department of Cardiology, Toyohashi Heart Center, Oyama-cho, Toyohashi, Japan.

出版信息

J Interv Cardiol. 2009 Aug;22(4):341-9. doi: 10.1111/j.1540-8183.2009.00485.x.

DOI:10.1111/j.1540-8183.2009.00485.x
PMID:19689658
Abstract
摘要

相似文献

1
Incomplete stent apposition after coronary stent implantation: myth or reality?冠状动脉支架植入术后支架贴壁不全：是误解还是确有其事？
J Interv Cardiol. 2009 Aug;22(4):341-9. doi: 10.1111/j.1540-8183.2009.00485.x.
2
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.依维莫司和紫杉醇洗脱支架置入术后 3 年的临床随访：来自 SPIRIT II（依维莫司洗脱冠状动脉支架系统治疗初发冠状动脉病变的临床评估）和 SPIRIT III（依维莫司洗脱冠状动脉支架系统[EECSS]治疗初发冠状动脉病变患者的临床评估）随机试验的汇总分析。
JACC Cardiovasc Interv. 2010 Dec;3(12):1220-8. doi: 10.1016/j.jcin.2010.07.017.
3
Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.在急性 ST 段抬高型心肌梗死患者行经皮冠状动脉介入治疗时植入药物洗脱支架时，不完全贴壁和延迟组织覆盖比在稳定/不稳定型心绞痛患者中植入药物洗脱支架时更常见：光学相干断层扫描的见解。
JACC Cardiovasc Interv. 2009 May;2(5):445-52. doi: 10.1016/j.jcin.2009.01.012.
4
Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials.比较急性和稳定型冠状动脉综合征患者中依维莫司洗脱支架和紫杉醇洗脱支架的疗效：来自 SPIRIT（依维莫司洗脱冠状动脉支架系统的临床评估）和 COMPARE（依维莫司洗脱支架和紫杉醇洗脱支架在日常实践中用于冠状动脉血运重建的比较试验）研究的汇总结果。
JACC Cardiovasc Interv. 2011 Oct;4(10):1104-15. doi: 10.1016/j.jcin.2011.06.018.
5
Five-year outcomes of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: are they equally good (or bad)?西罗莫司洗脱支架和紫杉醇洗脱支架在常规临床实践中的五年结果：它们同样好（或差）吗？
Circulation. 2011 Jun 21;123(24):2779-81. doi: 10.1161/CIRCULATIONAHA.111.033654. Epub 2011 Jun 6.
6
Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial.西罗莫司洗脱支架与紫杉醇洗脱支架随机比较的 5 年临床和血管造影结果：冠状动脉血运重建晚期紫杉醇洗脱支架与西罗莫司洗脱支架试验的结果。
Circulation. 2011 Jun 21;123(24):2819-28, 6 p following 2828. doi: 10.1161/CIRCULATIONAHA.110.004762. Epub 2011 Jun 6.
7
Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.多部位、多血管病变患者中应用依维莫司洗脱支架和紫杉醇洗脱支架的对比：SPIRIT III 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统（EECSS）的 XIENCE V 血管内介入器械的临床评估）和 SPIRIT IV 试验（在治疗初发冠状动脉病变患者中对依维莫司洗脱冠状动脉支架系统的 XIENCE V 血管内介入器械的临床评估）随机临床试验。
JACC Cardiovasc Interv. 2010 Dec;3(12):1229-39. doi: 10.1016/j.jcin.2010.09.014.
8
Cross-sectional and longitudinal positive remodeling after subintimal drug-eluting stent implantation: multiple late coronary aneurysms, stent fractures, and a newly formed stent gap between previously overlapped stents.
JACC Cardiovasc Interv. 2009 Feb;2(2):156-8. doi: 10.1016/j.jcin.2008.11.008.
9
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.用于无保护左主干冠状动脉疾病的紫杉醇洗脱支架与西罗莫司洗脱支架的比较
J Am Coll Cardiol. 2009 May 12;53(19):1760-8. doi: 10.1016/j.jacc.2009.01.035.
10
The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation.
Catheter Cardiovasc Interv. 2009 Jul 1;74(1):58-63. doi: 10.1002/ccd.21961.

引用本文的文献

1
Comparison of neointimal hyperplasia and peri-stent vascular remodeling after implantation of everolimus-eluting versus sirolimus-eluting stents: intravascular ultrasound results from the EXCELLENT study.依维莫司洗脱支架与西罗莫司洗脱支架植入后新生内膜增生和支架内血管重构的比较：EXCELLENT 研究的血管内超声结果。
Int J Cardiovasc Imaging. 2013 Aug;29(6):1229-36. doi: 10.1007/s10554-013-0199-5. Epub 2013 Mar 3.
2
Delivery technique plays an important role in determining vessel wall apposition of the Enterprise self-expanding intracranial stent.输送技术在确定 Enterprise 自膨式颅内支架的血管壁贴壁方面起着重要作用。
J Neurointerv Surg. 2011 Dec 1;3(4):340-3. doi: 10.1136/jnis.2010.004499. Epub 2011 Mar 9.
3
Parent vessel size and curvature strongly influence risk of incomplete stent apposition in enterprise intracranial aneurysm stent coiling.
载瘤动脉的大小和弯曲度强烈影响 Enterprise 颅内动脉瘤支架圈闭术中支架贴壁不完全的风险。
AJNR Am J Neuroradiol. 2011 Oct;32(9):1714-20. doi: 10.3174/ajnr.A2584. Epub 2011 Aug 4.